NCT00290758View on ClinicalTrials.gov

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

placebo

Given orally

DRUG

genistein

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00290758 - Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer | Biotech Hunter | Biotech Hunter